The transscleral diode laser contact cyclophotocoagulation in the treatment
for different glaucomas
Kramp K., Vick H.-P., Guthoff R.
Universitäts- Augenklinik Rostock, Doberaner Str. 140, 18055 Rostock
Objective: The transscleral cyclophotocoagulation (TSCPC) is of
increasing importance for the therapy of glaucoma as an alternative to
other surgical procedures. The purpose of this study was to evaluate the
short- and longterm clinical effectiveness of the TSCPC with the diode
laser for different types of glaucoma also as a primary surgical treatment.
Methods: A retrospective analysis after 250 TSCPC was made of 145
patients (193 eyes) with different glaucomas with an average age of 62,6
± 17,1 years treated between November 1994 and March 1998 in the
University Eye Hospital Rostock. Postoperative follow- up ranged from
6 to 48 months (Ø 13,9). Most of the patients have had Primary
Open Angle Glaucoma (POAG; 51,2 %) or secundary glaucoma (24,4 %). Neovascular
glaucoma (NVG) was only present in 5,2 %. Using a diode laser coupled
with a fiber optic probe ending in a focussing tip, all eyes were treated
with 24- 30 spots over 360° and 2,8- 3,6 J of energy, 1,5 mm posterior
to the limbus.
Results: The mean intraocular pressure (IOP) decreased from 24,6
± 6,7 mmHg before to 19,3 ± 5,7 mmHg after operation (p
< 0,001). Successfull control of IOP (final IOP in the range of 10-
22 mmHg ) occured in 76,4% after a single or multiple treatments. The
reduction of the maximal IOP as well as the number and frequency of application
of the antiglaucomatous medications was also statistically significant
(p < 0,001). The best results were obtained within the group of the
patients with POAG, in the group of the oldest and in the group of the
patients without any previous or following glaucoma operations. In often
refractory glaucomas, as NVG and congenital glaucomas, the reduction of
the IOP of 52,9 % respectively 15,0 % was successfully in 69,2 % respectively
58,3 %. 24,8 % of the cases were in need of multiple treatments with an
average of 1,3 per eye. There was a complication rate of 14,4 %, mostly
a mild uveitis (31 of 36). The phthisis bulbi as a serious complication
was observed in 2 patients with NVG and one woman with pseudoexfoliations
glaucoma.
Conclusion: The TSCPC with the diode laser is a save, effective
procedure with few severe complications in reducing the IOP in the treatment
of different glaucomas. It is also suited for a primary surgical treatment.
|